Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder

• Váldodahkkit: Athanasios Markopoulos (Dahkki), Antonio Inserra (Dahkki), Danilo De Gregorio (Dahkki), Gabriella Gobbi (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Recent clinical and preclinical evidence points towards empathogenic and prosocial effects elicited by psychedelic compounds, notably the serotonin 5-HT2A agonists lysergic acid diethylamide (LSD), psilocybin, N,N-Dimethyltryptamine (DMT), and their derivatives. These findings suggest a therapeutic...